09:00 EDT VistaGen Therapeutics trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTGN:
- Vistagen (NASDAQ:VTGN) Skyrockets over 600% on Positive Phase 3 Data for Social Anxiety Disorder
- Vistagen announces new itruvone data
- Vistagen receives notice of allowance for AV-101 Canadian patent
- Vistagen reports FY23 net loss $59.2M vs. $48.7M last year
- VTGN Upcoming Earnings Report: What to Expect?
Questions or Comments about the article? Write to editor@tipranks.com